Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness...
industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 01, 2022 7:51am
InMed Stocktwits Post
targatrader 6/30/22, 10:57 PM $INM is in the same position as $REVB was today. They had their S-/A TUTE offering announced a month ago and BOOMit explodes higher by 300%. It has been around the same
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Jul 01, 2022 7:47am
RE:Biotech Stocks
https://www.marketwatch.com/story/seven-reasons-the-beleaguered-biotech-sector-is-now-a-buy-11655475446
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 01, 2022 12:03am
Biotech Stocks
https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 28, 2022 7:50pm
News Wednesday ?
https://stocktwits.com/symbol/INM
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 26, 2022 6:47am
Hottest Cannabinoids
https://www.benzinga.com/amp/content/27358332
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 23, 2022 10:43pm
InMed Bezinga
https://youtu.be/rtssMjZ39lI
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 21, 2022 7:33am
Cronos and Gingko
InMed is way away of these guys d9 THCV, the more pure form of THCV. https://financialpost.com/globe-newswire/cronos-group-and-ginkgo-bioworks-announce-achievement-of-thcv-equity-milestone
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 16, 2022 7:18pm
Cannabinoid Trial Results
https://www.theleafonline.com/c/health-wellness/2022/06/breaking-news-historys-largest-cannabinoid-trial-on-pain-finds-significant-improvement/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 14, 2022 10:37pm
Oversold Conditions
https://finviz.com/quote.ashx?t=INM
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 14, 2022 7:38am
Peer Reciewed Study Publication
https://financialpost.com/globe-newswire/inmed-announces-publication-of-peer-reviewed-study-highlighting-potential-role-of-rare-cannabinoids-thcv-cbc-and-others-on-skin-conditions
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 14, 2022 7:30am
New Press Release - InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions
VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that a peer-reviewed scientific study entitled...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 11, 2022 9:41pm
InMed Headlines
https://www.schaeffersresearch.com/content/news/2022/06/10/this-weeks-cannabis-stock-news-7-companies-make-headlines
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 10, 2022 6:58am
Delta 9 THCV Study
Radicle Science is testing InMed's D9 THCV on 900 subjects right now. For those interested in scientific studies, a study from 2011 show positive results for: PTSD, panic and anxiety, Parkinson
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 09, 2022 6:39pm
THCV launch
https://thedalesreport.com/cannabis/inmed-launches-thcv-expanding-its-portfolio-of-rare-cannabinoids-for-the-health-and-wellness-sector/
(27)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Jun 09, 2022 9:02am
Excellent YT analysis on InMed Pharmaceuticals
https://youtu.be/YR3whoRE5lg
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study